PHILOGEN
Research PHILOGEN (PHIL.MI) on Bullrun: market cap EUR 887.22M, P/E 4.0, dividend yield 3.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPHIL.MI
- ExchangeMTAA
- CountryItaly
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 887.22M
- P/E4.0
- Dividend yield3.3%
- Financial periodFY2025
- RevenueEUR 314.33M
- Revenue growth324.8%
- Net incomeEUR 229.68M
- Free cash flowEUR 264.33M
- Gross margin98.3%
Valuation Snapshot
latest market cap is EUR 887.22M; P/E is 4.0; dividend yield is 3.3%.
Peer valuation comparison
Latest P/E is 3.95x versus a Healthcare sector median of 24.67x (84.0% below).
Latest dividend yield is 3.3% versus a Healthcare sector median of 1.84% (79.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 314.33M | EUR 229.68M | EUR 264.33M | 98.3% | 5.7 | EUR 127.20M | EUR 10.88M | EUR 373.86M |
| FY2024 | EUR 74.00M | EUR 45.29M | EUR 38.43M | 95.8% | 1.12 | EUR 30.57M | EUR 11.51M | EUR 138.66M |
| FY2023 | EUR 23.13M | -EUR 6.16M | -EUR 10.69M | 85.0% | -0.15 | EUR 15.64M | EUR 12.10M | EUR 90.59M |
| FY2022 | EUR 23.71M | -EUR 5.38M | -EUR 9.15M | 88.0% | -0.13 | EUR 24.44M | EUR 11.89M | EUR 97.92M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-05 | EUR 887.22M | 4.0 | 3.2% | 0.7 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.7 EUR, yield 3.3%.
About PHILOGEN
Philogen S.p.A., a biotechnology company, engages in the research and development of drugs for oncology and chronic inflammatory diseases in Italy, Switzerland, the United States, and the European Union. The company develops Nidlegy which is in Phase III clinical trial for the treatment of advanced melanoma and Phase II clinical trial for the treatment of basal cell carcinoma and cutaneous squamous cell carcinoma;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is PHILOGEN's market cap?
PHILOGEN's market capitalization is EUR 887.22M.
What is PHILOGEN's P/E ratio?
PHILOGEN's price-to-earnings (P/E) ratio is 4.0.
Does PHILOGEN pay a dividend?
PHILOGEN has a dividend yield of 3.3%.
What does PHILOGEN do?
Philogen S.p.A., a biotechnology company, engages in the research and development of drugs for oncology and chronic inflammatory diseases in Italy, Switzerland, the United States, and the European Union.